Industry Research Reports

Home > Reports > Medical Devices & Consumables > Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-01-24

Pages: 123 Pages

Report ld: 2332949

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Congestive Heart Failure (CHF) Treatment Devices Market Size(US$)

CAGR 2024-2030

3.1%

Market Size,2030

USD 6,369.4

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 5,303.3 million

Market Forecast in 2030(Value)

US$ 6,369.4 million

CAGR

3.1%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).

The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 4984.2 million in 2023 and is forecast to a readjusted size of US$ 6369.4 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Market Segmentation

By Company

Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Segment by Application

Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

biaoTi Report Scope

This report aims to provide a comprehensive presentation of the global market for Congestive Heart Failure (CHF) Treatment Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Congestive Heart Failure (CHF) Treatment Devices by region & country, by Type, and by Application.

The Congestive Heart Failure (CHF) Treatment Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congestive Heart Failure (CHF) Treatment Devices.

biaoTi Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Congestive Heart Failure (CHF) Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Congestive Heart Failure (CHF) Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Congestive Heart Failure (CHF) Treatment Devices in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction

1.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast

1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030)

1.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume (2019-2030)

1.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Price (2019-2030)

1.3 Congestive Heart Failure (CHF) Treatment Devices Market Trends & Drivers

1.3.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends

1.3.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers & Opportunity

1.3.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges

1.3.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Congestive Heart Failure (CHF) Treatment Devices Players Revenue Ranking (2023)

2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2019-2024)

2.3 Global Congestive Heart Failure (CHF) Treatment Devices Players Sales Volume Ranking (2023)

2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Company Players (2019-2024)

2.5 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Company (2019-2024)

2.6 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Congestive Heart Failure (CHF) Treatment Devices

2.9 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Analysis

2.9.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cardiac Resynchronization Therapy (CRT)

3.1.2 Implantable Cardioverter Defibrillators (ICDs)

3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type

3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Type (2019-2030)

3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Type (%) (2019-2030)

3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type

3.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Type (2019-2030)

3.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Type (%) (2019-2030)

3.4 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Left Ventricular Assist Device (LVAD)

4.1.2 Right Ventricular Assist Device (RVAD)

4.1.3 Biventricular Assist Device (BIVAD)

4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application

4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Application (2019-2030)

4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, by Application (%) (2019-2030)

4.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application

4.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Application (2019-2030)

4.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume, by Application (%) (2019-2030)

4.4 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region

5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2019-2024)

5.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2025-2030)

5.1.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (%), (2019-2030)

5.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region

5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2019-2024)

5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2025-2030)

5.2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (%), (2019-2030)

5.3 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

5.4.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

5.5.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

5.6.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

5.7.2 South America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

5.8.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value

6.2.1 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.2.2 Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.3.2 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.5.2 China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.5.3 China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.7.2 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.8.2 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019-2030

6.9.2 India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

6.9.3 India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abiomed

7.1.1 Abiomed Company Information

7.1.2 Abiomed Introduction and Business Overview

7.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.1.5 Abiomed Recent Development

7.2 Berlin Heart GmbH

7.2.1 Berlin Heart GmbH Company Information

7.2.2 Berlin Heart GmbH Introduction and Business Overview

7.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.2.5 Berlin Heart GmbH Recent Development

7.3 Biotronik SE & Co. KG

7.3.1 Biotronik SE & Co. KG Company Information

7.3.2 Biotronik SE & Co. KG Introduction and Business Overview

7.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.3.5 Biotronik SE & Co. KG Recent Development

7.4 Boston Scientific Corporation

7.4.1 Boston Scientific Corporation Company Information

7.4.2 Boston Scientific Corporation Introduction and Business Overview

7.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.4.5 Boston Scientific Corporation Recent Development

7.5 HeartWare International

7.5.1 HeartWare International Company Information

7.5.2 HeartWare International Introduction and Business Overview

7.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.5.5 HeartWare International Recent Development

7.6 Jarvik Heart

7.6.1 Jarvik Heart Company Information

7.6.2 Jarvik Heart Introduction and Business Overview

7.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.6.5 Jarvik Heart Recent Development

7.7 LivaNova PLC

7.7.1 LivaNova PLC Company Information

7.7.2 LivaNova PLC Introduction and Business Overview

7.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.7.5 LivaNova PLC Recent Development

7.8 Medtronic

7.8.1 Medtronic Company Information

7.8.2 Medtronic Introduction and Business Overview

7.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.8.5 Medtronic Recent Development

7.9 ReliantHeart

7.9.1 ReliantHeart Company Information

7.9.2 ReliantHeart Introduction and Business Overview

7.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.9.5 ReliantHeart Recent Development

7.10 Abbott

7.10.1 Abbott Company Information

7.10.2 Abbott Introduction and Business Overview

7.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offerings

7.10.5 Abbott Recent Development

8 Industry Chain Analysis

8.1 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain

8.2 Congestive Heart Failure (CHF) Treatment Devices Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Congestive Heart Failure (CHF) Treatment Devices Sales Model

8.5.2 Sales Channel

8.5.3 Congestive Heart Failure (CHF) Treatment Devices Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Congestive Heart Failure (CHF) Treatment Devices Market Trends

Table 2. Congestive Heart Failure (CHF) Treatment Devices Market Drivers & Opportunity

Table 3. Congestive Heart Failure (CHF) Treatment Devices Market Challenges

Table 4. Congestive Heart Failure (CHF) Treatment Devices Market Restraints

Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2019-2024)

Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Congestive Heart Failure (CHF) Treatment Devices Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Congestive Heart Failure (CHF) Treatment Devices

Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2019-2024) & (%)

Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Region (2025-2030) & (%)

Table 45. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2019-2024) & (%)

Table 49. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Region (2025-2030) & (%)

Table 50. Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume, (2025-2030) & (K Units)

Table 57. Abiomed Company Information

Table 58. Abiomed Introduction and Business Overview

Table 59. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 61. Abiomed Recent Development

Table 62. Berlin Heart GmbH Company Information

Table 63. Berlin Heart GmbH Introduction and Business Overview

Table 64. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 66. Berlin Heart GmbH Recent Development

Table 67. Biotronik SE & Co. KG Company Information

Table 68. Biotronik SE & Co. KG Introduction and Business Overview

Table 69. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 71. Biotronik SE & Co. KG Recent Development

Table 72. Boston Scientific Corporation Company Information

Table 73. Boston Scientific Corporation Introduction and Business Overview

Table 74. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 76. Boston Scientific Corporation Recent Development

Table 77. HeartWare International Company Information

Table 78. HeartWare International Introduction and Business Overview

Table 79. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 81. HeartWare International Recent Development

Table 82. Jarvik Heart Company Information

Table 83. Jarvik Heart Introduction and Business Overview

Table 84. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 86. Jarvik Heart Recent Development

Table 87. LivaNova PLC Company Information

Table 88. LivaNova PLC Introduction and Business Overview

Table 89. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 91. LivaNova PLC Recent Development

Table 92. Medtronic Company Information

Table 93. Medtronic Introduction and Business Overview

Table 94. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 96. Medtronic Recent Development

Table 97. ReliantHeart Company Information

Table 98. ReliantHeart Introduction and Business Overview

Table 99. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 101. ReliantHeart Recent Development

Table 102. Abbott Company Information

Table 103. Abbott Introduction and Business Overview

Table 104. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offerings

Table 106. Abbott Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Congestive Heart Failure (CHF) Treatment Devices Downstream Customers

Table 110. Congestive Heart Failure (CHF) Treatment Devices Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture

Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume (2019-2030) & (K Units)

Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Price (2019-2030) & (USD/Unit)

Figure 6. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered

Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Congestive Heart Failure (CHF) Treatment Devices Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2023

Figure 10. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Cardiac Resynchronization Therapy (CRT) Picture

Figure 12. Implantable Cardioverter Defibrillators (ICDs) Picture

Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Left Ventricular Assist Device (LVAD)

Figure 19. Product Picture of Right Ventricular Assist Device (RVAD)

Figure 20. Product Picture of Biventricular Assist Device (BIVAD)

Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Congestive Heart Failure (CHF) Treatment Devices Sales Volume (%), (2019-2030)

Figure 38. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 44. China Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 46. China Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 56. India Congestive Heart Failure (CHF) Treatment Devices Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Type (%), 2023 VS 2030

Figure 58. India Congestive Heart Failure (CHF) Treatment Devices Sales Value by Application (%), 2023 VS 2030

Figure 59. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain

Figure 60. Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

Related Reports

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-16
Pages: 94
USD 2900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-02-25
Pages: 86
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 110
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 115
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-16
Pages: 94
USD 2900.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-04-12
Pages: 107
USD 4900.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-02-25
Pages: 86
USD 2900.00 (Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 110
USD 3950.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 115
USD 2900.00 (Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 135
USD 3950.00 (Single User License)